Potential Adverse Events Reported With the Janus Kinase Inhibitors Approved for the Treatment of Rheumatoid Arthritis Using Spontaneous Reports and Online Patient Reviews

• Hoofdauteurs: Yun-Kyoung Song (Auteur), Junu Song (Auteur), Kyungim Kim (Auteur), Jin-Won Kwon (Auteur)
• Formaat: Boek
• Gepubliceerd in: Frontiers Media S.A., 2022-01-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

The aim of this study was to analyze the potential adverse events (AEs) caused by Janus kinase (JAK) inhibitors, including tofacitinib, baricitinib, and upadacitinib, used to treat rheumatoid arthritis using spontaneous AE reports from the FDA (FAERS) and interpreting them in correlation with those...